Application Of Multi-Specification Localization Needles In Full-Scenario Tumor Brachytherapy

1. Industry and Clinical Application Pain Points

In clinical tumor brachytherapy, single-specification puncture instruments cannot meet the differentiated surgical needs of different tumor types, lesion depths, and tissue densities, resulting in low treatment adaptation and uneven therapeutic effect. First, single large-gauge needles have strong rigidity but large trauma, easily causing excessive tissue damage and bleeding when applied to superficial micro-tumors and high-risk adjacent lesions, increasing postoperative complication risks. Second, single ultra-fine needles have minimal trauma but insufficient rigidity, prone to bending and deformation when puncturing deep and hard dense tumors, leading to trajectory deviation and surgical failure. Third, traditional single-structure needles cannot switch between vertical and multi-angle puncture modes freely, unable to adapt to regular planar implantation of superficial tumors and stereotactic implantation of irregular deep tumors simultaneously. Fourth, the lack of graded specification matching leads to unreasonable instrument selection in clinical surgery. Excessively thick needles cause unnecessary trauma, while excessively thin needles affect implantation stability, resulting in inconsistent surgical quality among different cases. In addition, traditional instruments have single functional configuration, unable to balance lubrication, visualization, and precise positioning performance in full scenarios, restricting the popularization and standardization of full-coverage brachytherapy treatment.

2. Core Working Principles of Full-Scenario Application

Radioactive particle localization needles adopt graded specification design and dual-structure configuration, with the core principle of realizing full-scene coverage of tumor brachytherapy through differentiated parameter matching and universal functional advantages. All product specifications adopt medical stainless steel base material, unified silicon lubrication coating, precision polished inner wall, echo-enhanced visualized tip, and electropolished high-sharpness structure, ensuring consistent core functional performance of all products. On this basis, through graded adjustment of needle gauge, tube wall thickness, and structural rigidity, differentiated scenario adaptation is realized: large-gauge needles enhance structural stability through thickened tube walls and reinforced swaging processes to adapt to high-pressure hard tissue puncture; medium-gauge needles adopt balanced structural design to balance trauma and stability for universal conventional scenarios; ultra-fine needles adopt precision necking thinning technology to realize ultra-minimally invasive puncture while avoiding deformation. Dual round and square hub structures switch freely to adapt to planar and stereotactic implantation needs. Combined with unified centimeter scale and foil orientation marking system, the product realizes standardized and unified operation logic in full scenarios, achieving precise treatment matching for different tumor characteristics.

3. Full-Scenario Equipment Classification and Application Matching

The product forms a complete graded specification matrix covering 8G to 20G full gauges and dual structures, realizing precise matching of all clinical brachytherapy scenarios. First, heavy-duty rigid needle series (8G–13G): processed by enhanced necking and swaging technology, with high structural strength and strong anti-extrusion ability, suitable for deep abdominal cavity, pelvic cavity, bone surface, and high-density fibrous tumor puncture, ensuring stable implantation trajectory and no deformation. Second, universal standard needle series (14G–16G): balanced tube wall thickness and rigidity, moderate trauma, widely applicable to breast, thyroid, lung, liver, and other conventional solid tumor brachytherapy, covering more than 70% of routine clinical cases. Third, ultra-fine minimally invasive needle series (18G–20G): ultra-thin tube body, minimal tissue damage, suitable for superficial small nodules, intracranial minor tumors, and lesions adjacent to important nerves and blood vessels, realizing ultra-safe precise implantation. Fourth, dual-structure full-scene matching: round hub needles for vertical planar implantation of regular tumors; square hub needles with orientation markers for multi-angle oblique stereotactic implantation of irregular and deep tumors. All series support customized parameter adjustment to fill individual scenario gaps.

4. Full-Scenario Standardized Operational Guidelines

To realize full-scene standardized application, clinical operations need to follow graded selection and unified process specifications. First, preoperative graded model selection: judge tumor depth, size, tissue density, and adjacent risk degree, select heavy-duty rigid needles for deep hard tumors, universal needles for routine medium-depth tumors, and ultra-fine needles for superficial high-risk micro-tumors; select round or square hubs according to tumor regularity and implantation angle requirements. Second, unified preoperative inspection standard: check coating integrity, inner wall smoothness, tip sharpness, imaging effect, and scale definition of all specification needles to ensure consistent functional performance. Third, scenario-based puncture operation: adopt low-pressure slow insertion for ultra-fine needles to avoid bending deformation; implement stable vertical advancement for heavy-duty needles to ensure trajectory accuracy; use square hub orientation adjustment for complex stereotactic implantation. Fourth, unified seed deployment standard: rely on polished inner wall to push particles evenly, control particle spacing uniformly, and ensure consistent dose distribution standards. Fifth, scenario-based intraoperative monitoring: strengthen real-time ultrasonic monitoring for high-risk superficial lesions, and focus on depth calibration for deep tumors to avoid over-penetration. Sixth, postoperative unified quality control: uniformly verify particle distribution and tumor coverage, and standardize surgical data filing standards for different specifications of needles.

5. Practical Experience of Full-Scenario Clinical Application

Full-scenario graded application practice verifies that the multi-specification localization needle matrix completely solves the problem of mismatched instruments in different tumor treatment scenarios. The graded specification matching mechanism enables clinical surgeons to select the most appropriate needle type according to lesion characteristics, avoiding excessive trauma caused by over-specification needles and surgical instability caused by under-specification needles. The unified core functional design ensures that all scenario surgeries can obtain the advantages of minimal invasion, visualization, and precise deployment, realizing consistent high-quality treatment effects. The dual-structure design realizes seamless switching between conventional and complex surgeries, greatly improving the coverage rate of minimally invasive brachytherapy. For primary tumors, recurrent tumors, superficial nodules, and deep hidden lesions of different sizes and densities, the product matrix can form targeted treatment schemes, realizing full-type tumor minimally invasive intervention. The full-scene application system standardizes clinical surgical operations, unifies treatment quality standards, and effectively promotes the large-scale popularization and standardized development of particle brachytherapy technology.

6. Summary and In-depth Conclusion

The multi-specification and full-scene application system of radioactive particle localization needles solves the industry's long-standing pain point of single instrument adaptation and uneven clinical treatment quality. Through graded rigid design and dual-structure configuration, it realizes precise matching of different tumor depths, densities, shapes, and surgical difficulty levels, covering all mainstream clinical brachytherapy scenarios. The unified core functional technology ensures that each specification product has excellent minimally invasive, visualized, and precise treatment capabilities, realizing full-scene high-quality treatment. The complete product matrix breaks the limitation of single instrument application, forms a standardized full-type tumor brachytherapy solution, greatly improves the clinical applicability and popularization value of particle implantation technology, and lays a solid foundation for the standardized and large-scale development of precise tumor radiotherapy.

7. Application Prospects and Optimization Suggestions

In the future, full-scene precise brachytherapy will become the mainstream development direction of tumor minimally invasive treatment, and multi-specification localization needles will have broader clinical application space. It is suggested to further refine the clinical grading application standard of needle specifications, form a unified industry needle selection guideline based on tumor location, size, and density, and standardize clinical operation behavior. Manufacturers can appropriately expand special specification needle types to fill the gap of ultra-long and ultra-short special-scene products. Clinically, strengthen the combined application of multi-specification combined implantation technology to improve the treatment effect of large-area and multi-focus tumors. Meanwhile, promote the intelligent matching of lesion data and needle specifications, realize automatic preoperative needle type recommendation, further improve the intelligence and standardization level of full-scene brachytherapy treatment, and drive the overall upgrading of industry treatment standards.